J. Goldman & Co’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-35,624	Closed	-$957K	–	204
2013 Q2	$957K	Buy	+35,624	New	+$957K	0.1%	122